Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75,679 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The protective effects of compatibility of Aconiti Lateralis Radix Praeparata and Zingiberis Rhizoma on rats with heart failure by enhancing mitochondrial biogenesis via Sirt1/PGC-1α pathway.
Lu X, Zhang L, Li P, Wang J, Li R, Huang Y, Wu M, Zhou H, Li Y, Wei S, Li K, Li H, Zhou X, Zhao Y, Xiao X. Lu X, et al. Among authors: huang y. Biomed Pharmacother. 2017 Aug;92:651-660. doi: 10.1016/j.biopha.2017.05.117. Epub 2017 Jun 2. Biomed Pharmacother. 2017. PMID: 28578259
The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-Analysis.
Ma X, Li RS, Wang J, Huang YQ, Li PY, Wang J, Su HB, Wang RL, Zhang YM, Liu HH, Zhang CE, Ma ZJ, Wang JB, Zhao YL, Xiao XH. Ma X, et al. Front Pharmacol. 2016 Mar 31;7:70. doi: 10.3389/fphar.2016.00070. eCollection 2016. Front Pharmacol. 2016. PMID: 27065861 Free PMC article. Review.
No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study.
Huang YQ, Tang SQ, Xu XL, Zeng YM, He XQ, Li Y, Harypursat V, Lu YQ, Wan Y, Zhang L, Sun QZ, Sun NN, Wang GX, Yang ZP, Chen YK. Huang YQ, et al. Front Pharmacol. 2020 Jul 14;11:1071. doi: 10.3389/fphar.2020.01071. eCollection 2020. Front Pharmacol. 2020. PMID: 32765274 Free PMC article.
Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol.
Zeng YM, Xu XL, He XQ, Tang SQ, Li Y, Huang YQ, Harypursat V, Chen YK. Zeng YM, et al. Among authors: huang yq. Chin Med J (Engl). 2020 May 5;133(9):1132-1134. doi: 10.1097/CM9.0000000000000790. Chin Med J (Engl). 2020. PMID: 32149772 Free PMC article. No abstract available.
75,679 results
You have reached the last available page of results. Please see the User Guide for more information.